Environment-sensitive hydrogels for drug delivery.

Highly stretchable and tough hydrogels. Nature (2012) 3.34

Engineering hydrogels as extracellular matrix mimics. Nanomedicine (Lond) (2010) 1.86

A magnetically triggered composite membrane for on-demand drug delivery. Nano Lett (2009) 1.77

Click chemistry, a powerful tool for pharmaceutical sciences. Pharm Res (2008) 1.67

Polymers for drug delivery systems. Annu Rev Chem Biomol Eng (2010) 1.66

Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater (2009) 1.60

Poly(ethylene glycol) hydrogels formed by thiol-ene photopolymerization for enzyme-responsive protein delivery. Biomaterials (2009) 1.56

Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov (2014) 1.39

Artificial Molecular Machines. Chem Rev (2015) 1.31

Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release. Nano Lett (2011) 1.31

Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng (2010) 1.25

Gelation-driven component selection in the generation of constitutional dynamic hydrogels based on guanine-quartet formation. Proc Natl Acad Sci U S A (2005) 1.19

Targeted Nanodelivery of Drugs and Diagnostics. Nano Today (2010) 1.18

Hydrophilic polymer embolism and associated vasculopathy of the lung: prevalence in a retrospective autopsy study. Hum Pathol (2014) 1.17

A temperature-sensitive drug release system based on phase-change materials. Angew Chem Int Ed Engl (2010) 1.16

Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials (2009) 1.15

Synthesis and characterization of a biodegradable elastomer featuring a dual crosslinking mechanism. Soft Matter (2010) 1.15

AP@home: a novel European approach to bring the artificial pancreas home. J Diabetes Sci Technol (2011) 1.12

Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics (2013) 1.12

Smart Polymeric Gels: Redefining the Limits of Biomedical Devices. Prog Polym Sci (2007) 1.11

Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems. Adv Drug Deliv Rev (2009) 1.10

Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev (2016) 1.08

A review of combined experimental and computational procedures for assessing biopolymer structure-process-property relationships. Biomaterials (2012) 1.06

Past, present, and future technologies for oral delivery of therapeutic proteins. J Pharm Sci (2008) 1.05

Graphene multilayers as gates for multi-week sequential release of proteins from surfaces. ACS Nano (2011) 1.04

Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials. Chem Rev (2015) 1.03

Qualitative analysis of controlled release ciprofloxacin/carbopol 934 mucoadhesive suspension. J Adv Pharm Technol Res (2011) 1.02

Drug delivery systems: Advanced technologies potentially applicable in personalized treatments. EPMA J (2010) 1.01

Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability. Biomacromolecules (2010) 1.00

Modified Gellan Gum hydrogels with tunable physical and mechanical properties. Biomaterials (2010) 0.96

Molecular nanofibers of olsalazine form supramolecular hydrogels for reductive release of an anti-inflammatory agent. J Am Chem Soc (2010) 0.96

Reversible maleimide-thiol adducts yield glutathione-sensitive poly(ethylene glycol)-heparin hydrogels. Polym Chem (2013) 0.95

On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles. Nat Med (2014) 0.95

Stimuli-sensitive hydrogels: a novel ophthalmic drug delivery system. Indian J Ophthalmol (2010) 0.94

Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response. J Mater Chem B Mater Biol Med (2012) 0.93

The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease. Biomaterials (2010) 0.93

Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int (2014) 0.93

Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine. Prog Polym Sci (2014) 0.92

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy. Int J Nanomedicine (2012) 0.92

Regulation of the matrix microenvironment for stem cell engineering and regenerative medicine. Ann Biomed Eng (2011) 0.90

Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet (2011) 0.90

Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer. Surg Today (2013) 0.90

Non-affine deformations in polymer hydrogels. Soft Matter (2012) 0.89

Degradable hydrogels for spatiotemporal control of mesenchymal stem cells localized at decellularized bone allografts. Acta Biomater (2014) 0.87

pH-triggered self-assembly of biocompatible histamine-functionalized triblock copolymers. Soft Matter (2013) 0.87

Sensing the cardiac environment: exploiting cues for regeneration. J Cardiovasc Transl Res (2011) 0.86

Transient modeling for kinetic swelling/deswelling of the ionic-strength-sensitive hydrogel. Eur Phys J E Soft Matter (2010) 0.85

Structural and rheological properties of chitosan semi-interpenetrated networks. Eur Phys J E Soft Matter (2010) 0.85

Micro/nanofabricated platforms for oral drug delivery. J Control Release (2015) 0.85

Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells. J Nanobiotechnology (2014) 0.85

Functional block copolymer nanoparticles: toward the next generation of delivery vehicles. Polym Chem (2012) 0.85

Computational Study of pH-sensitive Hydrogel-based Microfluidic Flow Controllers. J Funct Biomater (2011) 0.85

Lignosulfonate-mediated cellulase adsorption: enhanced enzymatic saccharification of lignocellulose through weakening nonproductive binding to lignin. Biotechnol Biofuels (2013) 0.84

Silk-elastin-like protein biomaterials for the controlled delivery of therapeutics. Expert Opin Drug Deliv (2014) 0.84

Thermoresponsive nanocomposite double network hydrogels. Soft Matter (2012) 0.84

Introduction of pH-Sensitivity into Mechanically Strong Nanoclay Composite Hydrogels Based on N-Isopropylacrylamide. J Polym Sci A Polym Chem (2008) 0.84

Therapeutic applications of hydrogels in oral drug delivery. Expert Opin Drug Deliv (2014) 0.84

Functional nucleic acid-based hydrogels for bioanalytical and biomedical applications. Chem Soc Rev (2016) 0.84

Stimulus-responsive hydrogels: Theory, modern advances, and applications. Mater Sci Eng R Rep (2015) 0.83

Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci Mater Med (2006) 0.83

Self-assembling Fmoc dipeptide hydrogel for in situ 3D cell culturing. BMC Biotechnol (2007) 0.83

Effects of crosslinking ratio, model drugs, and electric field strength on electrically controlled release for alginate-based hydrogel. J Mater Sci Mater Med (2012) 0.83

Stimuli sensitive polymers and self regulated drug delivery systems: a very partial review. J Control Release (2014) 0.83

Orthogonal switching of a single supramolecular complex. Nat Commun (2012) 0.83

Investigation of Swelling Behavior and Mechanical Properties of a pH-Sensitive Superporous Hydrogel Composite. Iran J Pharm Res (2012) 0.83

Negative thermo-responsive microspheres based on hydrolyzed gelatin as drug delivery device. AAPS PharmSciTech (2010) 0.82

Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel. Sci Rep (2014) 0.82

Temperature-triggered enzyme immobilization and release based on cross-linked gelatin nanoparticles. PLoS One (2012) 0.82

Smart polymers for the controlled delivery of drugs - a concise overview. Acta Pharm Sin B (2014) 0.82

Enteric micro-particles for targeted oral drug delivery. AAPS PharmSciTech (2010) 0.82

FTIR and Raman Spectroscopic Investigations of a Norfloxacin/Carbopol934 Polymeric Suspension. J Young Pharm (2012) 0.81

Steric stabilization of thermally responsive N-isopropylacrylamide particles by poly(vinyl alcohol). Langmuir (2010) 0.81

Preparation and characterization of nanosized P(NIPAM-MBA) hydrogel particles and adsorption of bovine serum albumin on their surface. Nanoscale Res Lett (2012) 0.81

Influence of crosslinker and ionic comonomer concentration on glass transition and demixing/mixing transition of copolymers poly(N-isopropylacrylamide) and poly(sodium acrylate) hydrogels. Colloid Polym Sci (2013) 0.81

Hyaluronic acid-based hydrogels containing covalently integrated drug depots: implication for controlling inflammation in mechanically stressed tissues. Biomacromolecules (2013) 0.81

Improving matrix metalloproteinase-2 specific response of a hydrogel system using electrophoresis. Int J Pharm (2012) 0.80

Ophthalmic light sensitive nanocarrier systems. Drug Discov Today (2008) 0.80

Triggered drug release from superhydrophobic meshes using high-intensity focused ultrasound. Adv Healthc Mater (2013) 0.80

Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy. J Nanomed Nanotechnol (2013) 0.80

Peptide-functionalized oxime hydrogels with tunable mechanical properties and gelation behavior. Biomacromolecules (2013) 0.80

Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin. J Mater Sci Mater Med (2010) 0.80

Novel functionalization of discrete polymeric biomaterial microstructures for applications in imaging and three-dimensional manipulation. ACS Appl Mater Interfaces (2014) 0.80

Micropatterned, clickable culture substrates enable in situ spatiotemporal control of human PSC-derived neural tissue morphology. Chem Commun (Camb) (2015) 0.79

Thermoresponsive hyperbranched copolymer with multi acrylate functionality for in situ cross-linkable hyaluronic acid composite semi-IPN hydrogel. J Mater Sci Mater Med (2011) 0.79

Smart Magnetically Responsive Hydrogel Nanoparticles Prepared by a Novel Aerosol-Assisted Method for Biomedical and Drug Delivery Applications. J Nanomater (2011) 0.79

Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer. Int J Nanomedicine (2015) 0.79

In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer. BMC Biotechnol (2009) 0.79

Hydrogels for delivery of bioactive agents: a historical perspective. Adv Drug Deliv Rev (2012) 0.79

Supramolecular interactions in chemomechanical polymers. Acc Chem Res (2009) 0.79

Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer. Surg Today (2014) 0.79

Integration of biosensors and drug delivery technologies for early detection and chronic management of illness. Sensors (Basel) (2013) 0.79

Poly (vinyl alcohol) hydrogels for pH dependent colon targeted drug delivery. J Mater Sci Mater Med (2008) 0.79

pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78

The release behavior and kinetic evaluation of tramadol HCl from chemically cross linked Ter polymeric hydrogels. Daru (2013) 0.78

Stimuli sensitive hydrogels for ophthalmic drug delivery: A review. Int J Pharm Investig (2012) 0.78

A general method to determine ionization constants of responsive polymer thin films. J Colloid Interface Sci (2011) 0.78

Endoscopic ultrasound-guided celiac plexus neurolysis using a reverse phase polymer. World J Gastroenterol (2010) 0.78

Multi-responsive hydrogels for drug delivery and tissue engineering applications. Regen Biomater (2014) 0.78

Stimuli-sensitive hydrogel based on N-isopropylacrylamide and itaconic acid for entrapment and controlled release of Candida rugosa lipase under mild conditions. Biomed Res Int (2014) 0.78

Biopolymer-connected liposome networks as injectable biomaterials capable of sustained local drug delivery. Biomacromolecules (2012) 0.78

Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity. J Clin Oncol (2001) 2.95

Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide. Anal Biochem (1992) 2.07

Synthesis of superporous hydrogels: hydrogels with fast swelling and superabsorbent properties. J Biomed Mater Res (1999) 1.95

Large variations in Southern Hemisphere biomass burning during the last 650 years. Science (2010) 1.95

Functional antagonism between YY1 and the serum response factor. Mol Cell Biol (1992) 1.91

Characterization of functional domains within the multifunctional transcription factor, YY1. J Biol Chem (1995) 1.88

A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res (1995) 1.86

Mouse down-regulated in adenoma (DRA) is an intestinal Cl(-)/HCO(3)(-) exchanger and is up-regulated in colon of mice lacking the NHE3 Na(+)/H(+) exchanger. J Biol Chem (1999) 1.84

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer. Ann Oncol (2013) 1.83

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol (2006) 1.81

Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst (1998) 1.81

Postoperative chemoradiotherapy for gastric cancer. Ann Oncol (2003) 1.73

Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med (2000) 1.71

The use of sterilised polyester mosquito net mesh for inguinal hernia repair in Ghana. Hernia (2008) 1.69

Connexin26 mutations associated with nonsyndromic hearing loss. Laryngoscope (2000) 1.69

Post-transcriptional regulation of the human transforming growth factor-beta 1 gene. J Biol Chem (1992) 1.68

Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology (2000) 1.65

Gastric retention properties of superporous hydrogel composites. J Control Release (2000) 1.64

Synthesis and characterization of superporous hydrogel composites. J Control Release (2000) 1.61

Protein adsorption on polymer surfaces: calculation of adsorption energies. J Biomater Sci Polym Ed (1990) 1.58

Congestion of right liver graft in living donor liver transplantation. Transplantation (2001) 1.51

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol (2007) 1.50

Severe impairment of salivation in Na+/K+/2Cl- cotransporter (NKCC1)-deficient mice. J Biol Chem (2000) 1.49

Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol Lett (2001) 1.47

Meal-induced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat. FASEB J (1989) 1.47

Paget's disease of the breast. Cancer (1970) 1.44

[Increased expression of hypoxia-inducible factor-1α and connective tissue growth factor accompanied by fibrosis in the rat testis of varicocele]. Actas Urol Esp (2012) 1.44

Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology (1999) 1.42

Bayesian analysis of pentaquark signals from CLAS data. Phys Rev Lett (2008) 1.39

Tricyclic antidepressant fatality: postmortem tissue concentrations. J Toxicol Clin Toxicol (2001) 1.38

Measurement of two- and three-nucleon short-range correlation probabilities in nuclei. Phys Rev Lett (2006) 1.37

Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis. J Clin Invest (1996) 1.33

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol (2001) 1.32

Cocaine-induced cortical microischemia in the rodent brain: clinical implications. Mol Psychiatry (2011) 1.31

Identification of a transcriptional initiator element in the cytochrome c oxidase subunit Vb promoter which binds to transcription factors NF-E1 (YY-1, delta) and Sp1. J Biol Chem (1993) 1.31

Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity. J Biomater Sci Polym Ed (1993) 1.31

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients. Br J Cancer (2009) 1.30

Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix. Exp Hematol (2001) 1.29

Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status. AJNR Am J Neuroradiol (2011) 1.29

Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Cancer Res (2001) 1.25

Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy. Ann Oncol (2011) 1.24

Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry (1998) 1.23

beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation (2001) 1.22

Unnatural conceptions: the study of monsters in sixteenth- and seventeenth-century France and England. Past Present (1981) 1.21

The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements. Mol Cell Biol (1993) 1.21

A domain of the gene 4 helicase/primase of bacteriophage T7 required for the formation of an active hexamer. J Biol Chem (1995) 1.20

Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. I. In vivo parameters and immunohistologic evidence suggesting microchimerism. Transplantation (1987) 1.20

Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers. Biomaterials (1992) 1.20

Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res (1998) 1.20

Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest (1995) 1.18

Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity. Eur J Immunol (2001) 1.17

Activation of vanilloid receptor 1 (VR1) by eugenol. J Dent Res (2003) 1.16

Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development. CNS Drugs (1997) 1.16

Surface modification using silanated poly(ethylene glycol)s. Biomaterials (2000) 1.15

Molecular cloning and functional expression of a rat Na+/H+ exchanger (NHE5) highly expressed in brain. J Biol Chem (1999) 1.15

A review of the literature for whole-body FDG PET in the management of patients with melanoma. Q J Nucl Med (2000) 1.14

Spontaneous intracranial hypotension: efficacy of radiologic targeting vs blind blood patch. Neurology (2011) 1.13

Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene (1998) 1.12

Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. Prostate Cancer Prostatic Dis (2013) 1.11

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br J Cancer (2008) 1.11

Structural features of the acetyl-CoA carboxylase gene: mechanisms for the generation of mRNAs with 5' end heterogeneity. Proc Natl Acad Sci U S A (1989) 1.10

Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum Gene Ther (2001) 1.09

Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. Br J Cancer (2005) 1.08

Searching the Porphyromonas gingivalis genome with peptide fragmentation mass spectra. Analyst (2001) 1.07

Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonatal Med (2002) 1.07

Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma. Ann Oncol (2008) 1.07

Small intestinal submucosa: a substrate for in vitro cell growth. J Biomater Sci Polym Ed (1998) 1.07

Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma. Invest New Drugs (2001) 1.06

Nerve growth factor induces transcription of transforming growth factor-beta 1 through a specific promoter element in PC12 cells. J Biol Chem (1994) 1.05

Three distinct chloride channels control anion movements in rat parotid acinar cells. J Physiol (1996) 1.05

Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. Eur J Cancer (2002) 1.05

Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J Control Release (2000) 1.05

Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study. Br J Cancer (2007) 1.05

DNA helicase requirements for DNA replication during bacteriophage T4 infection. J Bacteriol (1994) 1.04

Incidence of presbycusis of Korean populations in Seoul, Kyunggi and Kangwon provinces. J Korean Med Sci (2000) 1.03

Grafting of PEO to glass, nitinol, and pyrolytic carbon surfaces by gamma irradiation. J Biomed Mater Res (1997) 1.03

Laparoscopic nephrectomy for nonfunctioning tuberculous kidney. J Endourol (2000) 1.02

Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy. Antimicrob Agents Chemother (1997) 1.01

Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol (1999) 1.00

Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. J Urol (1997) 1.00

Assessing sources of inconsistencies in genotypes and their effects on genome-wide association studies with HapMap samples. Pharmacogenomics J (2010) 1.00

Laryngeal granuloma caused by short-term endotracheal intubation. Anesthesiology (1999) 1.00

Ratio of donor kidney weight to recipient bodyweight as an index of graft function. Lancet (2001) 1.00

Deconvolution of the circular dichroism spectra of proteins: the circular dichroism spectra of the antiparallel beta-sheet in proteins. Proteins (1992) 1.00

Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Anticancer Res (1999) 1.00

Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol (2002) 0.98

Amino Acids in Deep-Sea Water. Science (1962) 0.98

Axial penile buckling forces vs Rigiscan radial rigidity as a function of intracavernosal pressure: why Rigiscan does not predict functional erections in individual patients. Int J Impot Res (1999) 0.98

Modulated insulin delivery from glucose-sensitive hydrogel dosage forms. J Control Release (2001) 0.98

Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn J Cancer Res (1999) 0.97

Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients. Rheumatology (Oxford) (2008) 0.97

c-Myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer. J Korean Med Sci (1999) 0.97

Eugenol inhibits calcium currents in dental afferent neurons. J Dent Res (2005) 0.97

Upper gastrointestinal bleeding in an open-access dedicated unit. J R Coll Physicians Lond (1997) 0.96

Membrane-limited expression and regulation of Na+-H+ exchanger isoforms by P2 receptors in the rat submandibular gland duct. J Physiol (1998) 0.96

Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer (1998) 0.95

Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation. Breast Cancer Res Treat (1999) 0.95

Inhibition of protein phosphatases blocks myogenesis by first altering MyoD binding activity. J Biol Chem (1992) 0.95

Blast transformation of lymphocytes from newborn human infants. J Pediatr (1968) 0.95

Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol (1995) 0.94